Intelligence / Healthtech / New Clinical Trials / Galderma R&D
Clinicaltrial registered23 Oct 2026
Galderma R&D
23 Oct 2026: Trial registered · A Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 23 Oct 2026
- Title
- A Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™
- Conditions
- Midface Volume Deficit, Midface Contour Deficiency
- Study Type
- Observational
- Status
- Recruiting
- Countries
- China
- Country
- China
- Reference
- NCT07891767
- Location
- China
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Galderma R&D
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Galderma R&D in our registers.
More from China
New Clinical Trials
18 NovBeijing Baheal Wisart Medical Research Co., Ltdtrial registered · Safety, Tolerability, and Pharmacokinetic Study of Single and Multiple Ascending Dose of YY524051 Tablets in Healthy Adults.Clinical18 NovBeijing Xunsheng Biomedical Research Co., Ltd.trial registered · Safety, Tolerability, and Efficacy of a Therapeutic Intervention for HPV16/18 InfectionClinical18 NovCASI pharmaceuticals, Inc.trial registered · A Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaClinical18 NovEli Lilly and Companytrial registered · A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3839056 in Healthy ParticipantsClinical18 NovFujian Akeylink Biotechnology Co., Ltd.trial registered · A Study on the Pharmacokinetics and Safety of GST-HG141 Tablets in Participants With Hepatic Impairment and Normal Liver FunctionClinical18 NovGan & Lee Pharmaceuticals.trial registered · A Pharmacokinetics Study of GZR33 Injection at Different Injection SitesClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.